UNH
UnitedHealth Group Incorporated NYSE$370.75
Mkt Cap $336.5B
52w Low $234.60
77.8% of range
52w High $409.70
50d MA $301.25
200d MA $315.35
P/E (TTM)
27.9x
EV/EBITDA
15.4x
P/B
3.3x
Debt/Equity
0.8x
ROE
36.5%
P/FCF
18.7x
RSI (14)
—
ATR (14)
—
Beta
0.41
50d MA
$301.25
200d MA
$315.35
Avg Volume
9.1M
About
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care…
Recent Earnings
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 21, 2026 | AMC | 6.58 | 7.23 | +9.9% | 346.01 | +1.4% | +2.2% | +2.5% | +2.6% | +2.5% | +6.0% | — |
| Jan 27, 2026 | AMC | 2.10 | 2.11 | +0.5% | 282.70 | +0.4% | +4.0% | +3.4% | +1.5% | +1.0% | +0.5% | — |
| Oct 28, 2025 | AMC | 2.80 | 2.92 | +4.3% | 367.84 | -1.0% | -3.4% | -6.3% | -7.1% | -9.3% | -10.1% | — |
| Jul 29, 2025 | AMC | 4.45 | 4.08 | -8.3% | 261.07 | +1.4% | +1.9% | -4.4% | -8.9% | -7.7% | -3.9% | — |
| Apr 17, 2025 | AMC | 7.29 | 7.20 | -1.2% | 454.11 | -1.0% | -6.3% | -5.9% | -5.8% | -6.6% | -7.8% | — |
| Jan 16, 2025 | AMC | 6.74 | 6.81 | +1.0% | 510.59 | -1.0% | -0.2% | +2.8% | +1.8% | +3.8% | +4.3% | — |
| Oct 15, 2024 | AMC | 7.00 | 7.15 | +2.1% | 556.29 | +0.1% | +2.7% | +1.8% | +2.4% | +2.7% | +2.4% | — |
| Jul 16, 2024 | AMC | 6.65 | 6.80 | +2.3% | 548.87 | +0.9% | +4.4% | +2.8% | +3.0% | +1.8% | +1.1% | — |
| Apr 16, 2024 | AMC | 6.61 | 6.91 | +4.5% | 468.89 | +2.1% | +2.2% | +5.2% | +6.9% | +4.8% | +3.7% | — |
| Jan 12, 2024 | AMC | 5.98 | 6.16 | +3.0% | 521.51 | +0.4% | -0.5% | +0.7% | -1.0% | -3.4% | -1.6% | — |
Recent Analyst Ratings
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 28 | JP Morgan | Maintains | Overweight → Overweight | — | $354.69 | $356.84 | +0.6% | +3.4% | +4.5% | +4.5% | +4.0% | — |
| Apr 23 | TD Cowen | Maintains | Hold → Hold | — | $353.52 | $354.68 | +0.3% | +0.3% | +0.4% | +0.3% | +3.7% | +4.9% |
| Apr 22 | Truist | Maintains | Buy → Buy | — | $346.01 | $350.88 | +1.4% | +2.2% | +2.5% | +2.6% | +2.5% | +6.0% |
| Apr 22 | Leerink Partners | Maintains | Outperform → Outperform | — | $346.01 | $350.88 | +1.4% | +2.2% | +2.5% | +2.6% | +2.5% | +6.0% |
| Apr 22 | Barclays | Maintains | Overweight → Overweight | — | $346.01 | $350.88 | +1.4% | +2.2% | +2.5% | +2.6% | +2.5% | +6.0% |
| Apr 22 | RBC Capital | Maintains | Outperform → Outperform | — | $346.01 | $350.88 | +1.4% | +2.2% | +2.5% | +2.6% | +2.5% | +6.0% |
| Apr 22 | Oppenheimer | Maintains | Outperform → Outperform | — | $346.01 | $350.88 | +1.4% | +2.2% | +2.5% | +2.6% | +2.5% | +6.0% |
| Apr 22 | Wells Fargo | Maintains | Overweight → Overweight | — | $346.01 | $350.88 | +1.4% | +2.2% | +2.5% | +2.6% | +2.5% | +6.0% |
| Apr 22 | Argus | Upgrade | Hold → Buy | $400 | $346.01 | $350.88 | +1.4% | +2.2% | +2.5% | +2.6% | +2.5% | +6.0% |
| Apr 22 | Baird | Maintains | Underperform → Underperform | — | $346.01 | $350.88 | +1.4% | +2.2% | +2.5% | +2.6% | +2.5% | +6.0% |
Recent Filings
8-K
UNITEDHEALTH GROUP INCORPORATED (Delaware) -- 8-K Filing
UnitedHealth Group raised its 2026 adjusted earnings guidance to above $18.25 per share, signaling confidence in its healthcare modernization strategy and operational performance.
Apr 21
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
Uncertainty around leadership transitions at UnitedHealth could create near-term stock volatility, though investors should monitor whether the successor demonstrates capability to navigate ongoing regulatory pressures in healthcare.
Mar 12
8-K · 7.01
! Medium
UNITEDHEALTH GROUP INCORPORATED (Delaware) -- 8-K 7.01: Regulation FD Disclosure
UnitedHealth Group's senior leadership will discuss strategy, market positions, and business outlook at the Barclays Healthcare Conference on March 10, 2026, with live webcast access available.
Mar 9
8-K · 5.02
!!! Very High
UNITEDHEALTH GROUP INCORPORATED (Delaware) -- 8-K 5.02: Executive Change
UnitedHealth Group appoints Dennis Stankiewicz as director effective March 2, 2026, expanding its board composition with new governance representation.
Mar 2
8-K · 5.02
!!! Very High
UNITEDHEALTH GROUP INCORPORATED (Delaware) -- 8-K 5.02: Executive Change
UnitedHealth Group amended Stephen Hemsley's stock option grant with additional share-holding restrictions, extending incentive alignment beyond the original three-year cliff vesting period.
Feb 25
Data updated apr 27, 2026 6:50am
· Source: massive.com